Konjenital Kalp Hastalıklarında Sezaryen Anestezisi

Authors

Erdoğan Duran

Synopsis

Cesarean anesthesia management in pregnant women with congenital heart disease (CHD) requires a multidisciplinary approach involving a cardiologist, obstetrician, anesthesiologist, and pediatrician to minimize maternal and fetal morbidity and mortality. With advancements in early diagnosis and surgical treatment options, the number of patients with CHD reaching childbearing age is steadily increasing. In these patients, anesthetic management varies between left-to-right shunting lesions such as atrial septal defect (ASD), ventricular septal defect (VSD), and patent ductus arteriosus (PDA), and cyanotic abnormalities showing right-to-left shunting such as Tetralogy of Fallot (TOF) and Transposition of the Great Arteries (TGA). Physiological changes in pregnancy—including increased blood volume, cardiac output, and heart rate, along with decreased systemic vascular resistance and heightened thrombogenic risk due to alterations in coagulation mechanisms—challenge hemodynamic stability. Anesthetic planning should comprehensively evaluate cardiac pathology, shunt direction, and pregnancy-related physiological changes. While increases in systemic vascular resistance must be avoided in left-to-right shunts, maintaining systemic vascular resistance and preventing hypotension and hypoxia are critical in cyanotic lesions with right-to-left shunts. In high-risk pregnant women, invasive arterial monitoring should be established prior to Cesarean section, vasopressor agents should be readily available, neuraxial techniques preserving hemodynamics (such as epidural or combined spinal-epidural) or carefully titrated general anesthesia should be preferred, and the patient must be closely monitored during the first 12-24 peripartum hours.

References

Rao S, Ginns JN, editors. Adult congenital heart disease and pregnancy. Seminars in perinatology; 2014: Elsevier.

Blickman JG, Parker BR, Barnes PD. Pediatric radiology: the requisites e-book: Elsevier Health Sciences; 2009.

Chohan U, Afshan G, Mone A. Anaesthesia for caesarean section in patients with cardiac disease. JPMA The Journal of the Pakistan Medical Association. 2006;56(1):32-8.

Arendt KW, Berghella V, Connolly HM, et al. Anesthesia for labor and delivery in high-risk heart disease: General considerations.

Waksmonski C, Foley MJRN. Pregnancy in Women with Congenital Heart Disease: General Principles. 2016;14.

Ammash NM. Clinical manifestations and diagnosis of atrial septal defects in adults.

Yap SC, Drenthen W, Pieper PG, et al. Pregnancy outcome in women with repaired versus unrepaired isolated ventricular septal defect. BJOG : an international journal of obstetrics and gynaecology. 2010;117(6):683-9.

Anilkumar M. Patent ductus arteriosus. Cardiology clinics. 2013;31(3):417-30.

Doyle T, Kavanaugh-McHugh A, Triedman JKJUACU. Clinical manifestations and diagnosis of patent ductus arteriosus in term infants, children and adults. 2020.

Doyle T, Kavanaugh-McHugh A, Fish FAJU, Published. Management and outcome of tetralogy of Fallot. 2019.

Torres-Gómez LG, Iñigo-Riesgo CA, Espinoza-Ortegón MA, et al. [Pregnancy and tetralogy of Fallot with and without surgical correction]. Ginecologia y obstetricia de Mexico. 2010;78(6):309-15.

Tan S, İpek A, M., Keskin L. Importance of Fetal Ultrasonography in Transposition of the Great Arteries: Case Report. Journal of Clinical Obstetrics & Gynecology.20(1):67-70.

Connolly HM, Grogan M, Warnes CAJJotAcoC. Pregnancy among women with congenitally corrected transposition of great arteries. 1999;33(6):1692-5.

Tsuda A, Nagaoka K, Hashiguchi H, et al. [Anesthetic management of a pregnant patient with congenitally corrected transposition of the great arteries for emergency cesarean delivery]. Masui The Japanese journal of anesthesiology. 2003;52(2):187-9.

Akpinar O. Gebelik ve kapak hastaliklari/Pregnancy and heart valve disease: The Anatolian Journal of Cardiology. Anadulu Kardiyoloji Dergisi : AKD. 2009;9:25-34.

Chapman AB, Abraham WT, Zamudio S, et al. Temporal relationships between hormonal and hemodynamic changes in early human pregnancy. Kidney international. 1998;54(6):2056-63.

Robson SC, Hunter S, Boys RJ, et al. Serial study of factors influencing changes in cardiac output during human pregnancy. The American journal of physiology. 1989;256(4 Pt 2):H1060-5.

Yeomans ER, Gilstrap LC, 3rd. Physiologic changes in pregnancy and their impact on critical care. Critical care medicine. 2005;33(10 Suppl):S256-8.

McFaul PB, Dornan JC, Lamki H, et al. Pregnancy complicated by maternal heart disease. A review of 519 women. British journal of obstetrics and gynaecology. 1988;95(9):861-7.

Hunter S, Robson SC. Adaptation of the maternal heart in pregnancy. British heart journal. 1992;68(6):540-3.

Brown MA, Gallery ED. Volume homeostasis in normal pregnancy and pre-eclampsia: physiology and clinical implications. Bailliere's clinical obstetrics and gynaecology. 1994;8(2):287-310.

Lockitch G. Clinical biochemistry of pregnancy. Critical reviews in clinical laboratory sciences. 1997;34(1):67-139.

Ozanne P, Linderkamp O, Miller FC, Meiselman HJ. Erythrocyte aggregation during normal pregnancy. American journal of obstetrics and gynecology. 1983;147(5):576-83.

Danik S, Fuster V. Anticoagulation in pregnant women with prosthetic heart valves. The Mount Sinai journal of medicine, New York. 2004;71(5):322-9.

Hamlyn EL, Douglass CA, Plaat F, et al. Low-dose sequential combined spinal-epidural: an anaesthetic technique for caesarean section in patients with significant cardiac disease. International journal of obstetric anesthesia. 2005;14(4):355-61.

Buhre W, Disma N, Hendrickx J, et al. European Society of Anaesthesiology Task Force on Nitrous Oxide: a narrative review of its role in clinical practice. British journal of anaesthesia. 2019;122(5):587-604.

Pages

153-162

Published

November 17, 2021

License

License